ADHD

The ADHD-Depression Connection in Teenagers: What Every Parent Should Know

Depression is common in teenagers with ADHD, and the two are often causally linked rather than coincidental. How the connection works, what to watch for, and which signs need attention today.

  • Plain Language
  • Patient Focused

As a psychiatric nurse practitioner who treats both ADHD and depression in teens, I see this overlap every week. And the most important thing I can tell parents is this: if your teen has both, treating only one will not fix the other.

If your teen has talked about not wanting to be here

Call or text 988 — the Suicide and Crisis Lifeline — or text HOME to 741741 for the Crisis Text Line. Both are free, confidential and available 24/7. You can call as a parent seeking advice about your child, not only during an emergency.⁠7

Go to an emergency department if your teen has harmed themselves or you believe they are at immediate risk.

You do not need to be certain before you call. Teenagers with ADHD are at substantially higher risk than their peers, and reaching out early is the right call.⁠1

Depression is substantially more common in teenagers with ADHD than in their peers, and the two are often causally linked rather than coincidental — years of effort without results wear down how a teenager sees themselves. Treating only one usually leaves the other running. The combination also carries real risk, which is why this page starts with a crisis number rather than ending with one.⁠1,2

Key Takeaways

  • Depression in teens with ADHD is common enough to expect and watch for. Psychiatric comorbidity in ADHD runs 40–80% across studies, with depressive disorders specifically reported at 5–26%.⁠2
  • The link is often causal, not coincidental. Repeated failure, social friction and executive function overwhelm create the conditions depression grows in.
  • ADHD raises suicide risk. A meta-analysis of nine longitudinal studies found odds of suicidal ideation, attempt and death all roughly three to four times higher in children and adolescents with ADHD.⁠1
  • Symptoms overlap heavily, and the sequence matters: ADHD is neurodevelopmental and was there first.
  • Treating only one often fails. An antidepressant does not fix executive function; a stimulant does not resolve established depression.
  • Keep therapy when medication starts. In the largest adolescent depression trial, suicidal events were roughly half as common on combination treatment as on medication alone.⁠6
  • Pharmacogenomic testing is not recommended for this age group. AACAP advises clinicians to avoid it in children and adolescents.⁠4

How ADHD leads to depression

ADHD does not cause depression the way a virus causes a cold. It creates the conditions for depression to develop — slowly, cumulatively, and often invisibly.

The failure cycle

A teen with ADHD tries hard, falls short, tries harder, falls short again — across academics, friendships, sports, chores and family expectations, sometimes dozens of times a day.

Over months and years, that repeated experience of effort without results reshapes how a teenager sees themselves. The internal narrative shifts from that was hard to I am not good enough to why bother trying. That last stage is the psychological territory depression occupies.

Social friction and withdrawal

ADHD affects social functioning in ways that are easy to miss. Impulsivity leads to interrupting, saying the wrong thing, or overreacting to minor conflict. Inattention leads to forgotten plans, missed cues and appearing disinterested. Inconsistency — engaged one day, distracted the next — confuses peers.

By mid-adolescence, many teens with ADHD have accumulated enough social friction to start pulling back. The withdrawal looks like depression because, eventually, it becomes depression.

The executive function overwhelm spiral

ADHD affects executive function — planning, prioritizing, initiating tasks, managing time. For a teenager facing increasingly complex demands, that produces chronic overwhelm. Overwhelm leads to avoidance, avoidance leads to falling behind, falling behind leads to shame. Shame that accumulates silently over months is fertile ground for depression.

Shared biology

There is a biological dimension. ADHD and depression both involve catecholamine systems — dopamine and norepinephrine — which affect motivation, reward processing and mood, and the two conditions share genetic risk.

A caution about how this gets described. You will often read that ADHD or depression is a “chemical imbalance” that medication corrects. There is no measurable deficiency being replaced, and no test for one. The shared biology is real; the deficiency framing is not, and a family who later learns that may distrust everything else they were told.

How common is depression in teens with ADHD?

Common enough to watch for actively, and the honest answer is a range rather than a single figure.

Overall psychiatric comorbidity in children and adolescents with ADHD ranges from 40% to 80% across studies, with large variability in the rate reported for each individual condition. Depressive disorders specifically are reported at 5% to 26%.⁠2

For context, depression in the general adolescent population rises to roughly 6% by middle-to-late adolescence, with a sixfold increase between ages 15 and 18.⁠3

Why the variation matters. Studies differ in how they diagnose, who they sample and what age range they cover. Any source giving you one confident percentage is smoothing over that. What is not in dispute is the direction: elevated, and worth monitoring for.

Why this combination carries higher risk

This is the section the previous version of this page did not have, and it is the reason the crisis box sits at the top.

A systematic review and meta-analysis of nine longitudinal studies — samples ranging from 104 to 86,670 participants — found significantly elevated odds among children and adolescents with ADHD for overall suicidality (OR 3.34), suicidal ideation (OR 3.96), suicide attempt (OR 3.34) and death (OR 3.89).⁠1

How to hold this. Not as a reason for alarm — most teens with ADHD and depression do well with treatment. As a reason to know the number before you need it, take hopelessness statements seriously the first time, and not wait to see whether things settle.

Is it ADHD, depression, or both?

This is where misdiagnosis happens, because the symptom lists overlap heavily.

Looks like depression, but is ADHDAppears in bothLooks like ADHD, but is depression
Fatigue from all-day compensatingDifficulty concentratingForgetfulness
IrritabilityLow motivationIndecisiveness
Social withdrawal after repeated frictionPoor academic performancePsychomotor slowing
Restlessness mistaken for agitationSocial withdrawalLoss of interest in activities

A teen with undiagnosed ADHD who has developed secondary depression can present as though they “just” have depression. If only the depression is treated, the underlying ADHD keeps driving the failure cycle that produced it.

The sequence is the diagnostic key. ADHD is neurodevelopmental — symptoms are present before age 12 by definition. Depression typically emerges later. A good evaluation traces the timeline: when did attention difficulties start, when did mood changes begin, and which came first?

If your teen has been diagnosed with depression and treatment is not working, it is worth asking their provider whether ADHD has been considered.

Why treating both matters

Medication

Stimulant medication can improve focus, motivation and task completion, which often lifts mood because the failure cycle slows. But where clinical depression is established, a stimulant alone may not be enough. Conversely, an antidepressant without addressing ADHD may improve mood temporarily while executive function difficulties remain — and without the ability to follow through, the same pressures rebuild.

Sequencing depends on severity, symptom timeline and individual response. There is no formula. What is worth knowing is that in the largest trial of adolescent depression treatment, combination treatment outperformed either alone — 71.0% response for medication plus CBT against 60.6% for medication alone and 43.2% for CBT alone⁠5 — and suicidal events were more common with medication alone (14.7%) than combination treatment (8.4%), leading the authors to conclude that adding CBT enhances the safety of medication.⁠6 That is a strong argument for not dropping therapy when medication starts. See ADHD medication management.

On genetic testing for medication selection

You may be offered pharmacogenomic testing — commercial panels marketed as predicting which psychiatric medications will suit your teen. This is not currently recommended for adolescents, and it is worth knowing why before you pay for one.

The American Academy of Child and Adolescent Psychiatry recommends that clinicians avoid using pharmacogenetic testing to select psychotropic medications in children and adolescents, pending high-quality prospective studies in this population. It notes that current studies are limited by potential conflicts of interest, small sample sizes, short follow-up, lack of blinding and lack of appropriate control groups — and, specifically, that testing provides little meaningful information when two or more medications are used concurrently, which is exactly the situation it is most often marketed for.⁠4

The FDA issued a safety communication in October 2018 warning against genetic tests with unapproved claims to predict medication response, stating that changing a regimen on the basis of such results leads to “inappropriate treatment decisions and potentially serious health consequences for the patient.”⁠4

If a provider recommends testing, ask which specific genes, why for your teen, what it costs, and what they would do differently with the result. Those are fair questions, and a good clinician will answer them.

Therapy

CBT is effective for both conditions, but the targets differ. For ADHD: executive function strategies — breaking tasks down, building routines, managing time. For depression: the cognitive patterns that have calcified over years. A good therapist works on both: rebuilding self-concept while equipping the teen with tools to function differently.

Family understanding

When a teen has both, family dynamics often lock into frustration and guilt. Parents push harder because they see potential. The teen shuts down because pushing harder does not help when the difficulty is neurological. Understanding that both are brain-based rather than character-based changes the whole conversation.

What to watch for

Raise at the next appointment

  • Persistent sadness or emptiness lasting more than two weeks, beyond normal teen moodiness
  • Loss of interest in activities they used to enjoy, especially social ones
  • Sleep changes — significantly more or less than usual
  • Appetite or weight changes
  • Increased irritability — anger and irritability are more common depression markers in teens than visible sadness
  • Physical complaints — headaches, stomachaches, fatigue without medical explanation
  • Declining performance despite effort

Seek help today

Call or text 988, contact your pediatrician urgently, or go to an emergency department for any of these:

  • Any statement about not wanting to be here, being a burden, or things being pointless — including “what’s the point,” “nothing matters,” “I don’t care anymore”
  • Self-harm, or evidence of it
  • Giving away possessions, or saying goodbye in ways that feel final
  • A sudden lift in mood after a long low period, without an obvious reason
  • Total withdrawal — not leaving their room, not eating with the family
  • Your own strong instinct that something is badly wrong

You do not need certainty to act. Crisis lines are for parents seeking advice about their child, not only for emergencies already in progress.

How to get help

  1. If there is any safety concern, start there — 988, your pediatrician, or an emergency department.
  2. Ask your teen’s current provider directly whether both conditions have been assessed.
  3. Request a psychiatric evaluation if only one has been. See when therapy is not enough for what an evaluation involves.
  4. Bring the timeline. When did attention difficulties start? When did mood change? Which came first? That sequence does more diagnostic work than any symptom list.
  5. Keep therapy going if medication starts. The evidence favors both.⁠6
  6. Include your teen in the decisions. By adolescence, treatment they had no say in is treatment they will resist.

You can find a therapist or browse providers by state through our directory, and our cost and insurance guides cover funding.

Frequently Asked Questions

How common is depression in teens with ADHD?

Common enough to watch for actively. Overall psychiatric comorbidity in children and adolescents with ADHD runs 40% to 80% across studies, with depressive disorders specifically reported at 5% to 26%. For context, depression in the general adolescent population reaches roughly 6% by middle-to-late adolescence.

Does ADHD cause depression?

Not directly, but it creates the conditions for it. Repeated effort without results across school, friendships and family reshapes how a teenager sees themselves; social friction leads to withdrawal; and executive function difficulties produce chronic overwhelm, avoidance and shame. The two also share genetic risk and overlapping neurobiology.

Are teens with ADHD at higher risk of suicide?

Yes, and this is why it matters to act early. A meta-analysis of nine longitudinal studies found children and adolescents with ADHD had roughly three to four times higher odds of suicidal ideation, suicide attempt and death than their peers. If your teen has talked about not wanting to be here, call or text 988.

How do I tell whether it is ADHD, depression, or both?

The symptom lists overlap heavily — difficulty concentrating, low motivation, poor performance and social withdrawal appear in both. The sequence is the key. ADHD is neurodevelopmental, with symptoms present before age 12 by definition, while depression typically emerges later. A good evaluation traces when attention difficulties started, when mood changed, and which came first.

My teen is being treated for depression but is not improving. What now?

Ask their provider whether ADHD has been considered. If only the depression is treated, the underlying ADHD keeps driving the pressures that produced it — the failure cycle continues regardless of how the mood symptoms are managed.

Should my teen have genetic testing to choose their medication?

Not currently recommended for this age group. The American Academy of Child and Adolescent Psychiatry recommends that clinicians avoid using pharmacogenetic testing to select psychotropic medications in children and adolescents, noting that current studies are limited by conflicts of interest, small samples, short follow-up and lack of control groups, and that testing provides little meaningful information when two or more medications are used concurrently. The FDA has separately warned against genetic tests with unapproved claims to predict medication response.

Does starting medication mean stopping therapy?

No, and the evidence argues specifically against it. In the largest adolescent depression trial, response was 71.0% for medication plus CBT against 60.6% for medication alone, and suicidal events were more common with medication alone (14.7%) than combination treatment (8.4%). The authors concluded that adding CBT enhances the safety of medication.

Can treating ADHD improve the depression on its own?

Sometimes, particularly where the depression is secondary and recent — improving focus and task completion slows the failure cycle, which lifts mood. Where clinical depression is established, a stimulant alone is often not enough. That decision belongs with a prescriber who knows your teen.

What are the depression warning signs specific to teenagers?

Irritability and anger are more common markers than visible sadness at this age. Also watch for loss of interest in previously enjoyed activities, sleep or appetite changes, unexplained physical complaints, and withdrawal from friends. Any statement about not wanting to be here needs same-day attention rather than monitoring.

Sources

  1. Garas P, Balazs J, et al. Longitudinal suicide risk in children and adolescents with attention deficit and hyperactivity disorder: a systematic review and meta-analysis. Brain and Behavior. 2025;15(6):e70618. PMID 40534226. — Nine longitudinal studies; samples of participants with ADHD ranged from 104 to 86,670, with a mean age between 5.2 and 14.94 years. Average odds ratios were significant for overall suicidality (OR 3.336, 95% CI 2.201–5.057), suicidal ideation (OR 3.956, 95% CI 1.996–7.841), suicide attempt (OR 3.344, 95% CI 1.682–6.650) and death (OR 3.891, 95% CI 2.103–7.198).
  2. Reale L, Bartoli B, Cartabia M, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. European Child & Adolescent Psychiatry. 2017;26(12):1443–1457. doi:10.1007/s00787-017-1005-z. — Overall prevalence of comorbidity in children and adolescents with ADHD ranges from 40% to 80%, with large variability in the reported rate of individual disorders. Oppositional defiant disorder is the most prevalent at 20–60%, followed by anxiety disorders at 1–44% and depressive disorders at 5–26%.
  3. Wang S, Stewart TM, Ozen I, Mukherjee A, Rhodes SM. Rates of depression in children and adolescents with ADHD: a systematic review and meta-analysis. Journal of Attention Disorders. 2025. doi:10.1177/10870547251341597. — In the neurotypical population, depression prevalence rises to approximately 6% during middle-to-late adolescence, with a sixfold increase between ages 15 and 18.
  4. American Academy of Child and Adolescent Psychiatry. Clinical use of pharmacogenetic tests in prescribing psychotropic medications for children and adolescents. Policy Statement, 2020. aacap.org. — “The American Academy of Child and Adolescent Psychiatry recommends: Clinicians avoid using pharmacogenetic testing to select psychotropic medications in children and adolescents.” Current studies are limited by potential conflicts of interest, small sample sizes, short duration of follow-up, lack of blinding and lack of appropriate control groups. Pharmacogenomic testing provides little meaningful information when two or more medications are used concurrently. In October 2018 the Food and Drug Administration issued a safety communication warning against the use of genetic tests with unapproved claims to predict medication response, noting that changing a regimen on such results leads to “inappropriate treatment decisions and potentially serious health consequences for the patient.”
  5. March J, Silva S, Petrycki S, et al.; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA. 2004;292(7):807–820. PMID 15315995. — 439 patients aged 12 to 17. Response rates: fluoxetine with CBT 71.0%, fluoxetine alone 60.6%, CBT alone 43.2%, placebo 34.8%.
  6. March J, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Archives of General Psychiatry. 2007;64(10):1132–1143. PMID 17909125. — Suicidal events were more common in patients receiving fluoxetine therapy (14.7%) than combination therapy (8.4%) or CBT (6.3%). The authors conclude that adding CBT to medication enhances the safety of medication.
  7. 988 Suicide & Crisis Lifeline (United States). Call or text 988. 988lifeline.org. Crisis Text Line: text HOME to 741741.

Medical disclaimer. This page is for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your child. If your teen has expressed thoughts of suicide or self-harm, or you are worried about their immediate safety, call or text 988 (US) or go to your nearest emergency department. Decisions about medication should be made with a qualified prescriber who knows your teen.